《異動股》醫脈通(02192.HK)挫逾13%創上市低
醫脈通(02192.HK)今早(5日)高開1.1%報27元後,隨即轉跌,午後跌幅擴大,現跌13.5%,報23.1元創去年7月中上市以來新低,成交189.4萬股,涉4,621.2萬元。公司股價自上市起逐漸走高,至去年11月底創47元高位後輾轉回落;現價較去年7月上市價27.2元低15.1%。
公司是內地最大在線專業醫師平臺,去年中在港上市,引入包括FMR、富達國際、騰訊(00700.HK)全資附屬Tencent Mobility、GIC、Matthews Funds、Springhill及OrbiMed Funds七名基石投資者,集資淨額約40億元,主要用作未來三至五年內擴展業務及投資技術和提高研發能力、用於有精心挑選戰略投資或收購機會等。
至於其投資者之一騰訊已宣佈減持新加坡遊戲及電商公司Sea(SE.US)約1,450萬股股份,持股比例從21.3%降至18.7%。騰訊稱,今次減持是要釋放對Sea的部分投資價值,併爲騰訊其他投資及社會責任項目提供資金,但重申有意長期持有Sea的大部分股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.